Dermato Dr JASON: what changed
What changed
Dermato Dr JASON
filed annual accounts (NBB)
Net result for the year
€47,583
2024 · €39,838+€7,746
Equity
€200,289
2024 · €185,705+€14,583
Cash
€363,063
2024 · €301,663+€61,400
Balance sheet total
€364,829
2024 · €306,836+€57,993
Largest movements
Assets
- Cash +€61,400
up €61,400 (+20.4%), from €301,663 to €363,063
mainly Net result for the year (+€47,583) and Other debts (+€34,110)
Equity and liabilities
- Other debts +€34,110
up €34,110 (+30.5%), from €111,985 to €146,095
- Reserves +€14,500
up €14,500 (+8.6%), from €167,921 to €182,421
of which Distributable reserves: +€14,500
- Tax, wage and social debts +€7,181
up €7,181 (+144%), from €5,002 to €12,183
Income statement
- Gross operating margin +€10,756
up €10,756 (+17.0%), from €63,167 to €73,923
- Financial charges +€3,478
up €3,478 (+63.6%), from €5,467 to €8,944
- Financial income +€1,103
up €1,103 (+563%), from €196 to €1,298
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€39,838
Gross operating margin
+€10,756
Depreciation
-€0
Other operating charges
-€21
Financial income
+€1,103
Financial charges
-€3,478
Taxes
-€614
Result 2025
€47,583
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€94,400
Investment
€0
Financing
-€33,000
Cash 2024
€301,663
From operations (derived)
+€94,400
Net result for the year
+€47,583
Depreciation
+€1,056
Receivables within one year
+€2,348
Deferred charges and accrued income
+€3
Trade debts
-€160
Tax, wage and social debts
+€7,181
Other debts
+€34,110
Accrued charges and deferred income
+€2,279
Financing
-€33,000
Contributions, distributions and other
-€33,000
Cash 2025
€363,063
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €306,836 | €364,829 | +€57,993 | +18.9% |
| Fixed assets | 21/28 | €2,326 | €1,270 | -€1,056 | -45.4% |
| Tangible fixed assets | 22/27 | €2,326 | €1,270 | -€1,056 | -45.4% |
| Furniture and vehicles | 24 | €2,326 | €1,270 | -€1,056 | -45.4% |
| Current assets | 29/58 | €304,510 | €363,560 | +€59,050 | +19.4% |
| Amounts receivable within one year | 40/41 | €2,348 | - | -€2,348 | |
| Other amounts receivable | 41 | €2,348 | - | -€2,348 | |
| Cash at bank and in hand | 54/58 | €301,663 | €363,063 | +€61,400 | +20.4% |
| Deferred charges and accrued income | 490/1 | €499 | €496 | -€3 | -0.5% |
| Total equity and liabilities | 10/49 | €306,836 | €364,829 | +€57,993 | +18.9% |
| Equity | 10/15 | €185,705 | €200,289 | +€14,583 | +7.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €167,921 | €182,421 | +€14,500 | +8.6% |
| Tax-exempt reserves | 132 | €3,000 | €3,000 | = | 0.0% |
| Distributable reserves | 133 | €164,921 | €179,421 | +€14,500 | +8.8% |
| Profit (loss) carried forward | 14 | €5,385 | €5,468 | +€83 | +1.6% |
| Amounts payable | 17/49 | €121,131 | €164,541 | +€43,410 | +35.8% |
| Amounts payable within one year | 42/48 | €118,690 | €159,822 | +€41,131 | +34.7% |
| Trade debts | 44 | €1,703 | €1,543 | -€160 | -9.4% |
| Suppliers | 440/4 | €1,703 | €1,543 | -€160 | -9.4% |
| Taxes, remuneration and social security | 45 | €5,002 | €12,183 | +€7,181 | +144% |
| Taxes | 450/3 | €5,002 | €12,183 | +€7,181 | +144% |
| Other amounts payable | 47/48 | €111,985 | €146,095 | +€34,110 | +30.5% |
| Accrued charges and deferred income | 492/3 | €2,441 | €4,719 | +€2,279 | +93.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,056 | €1,056 | +€0 | 0.0% |
| Other operating charges | 640/8 | €1,038 | €1,059 | +€21 | +2.0% |
| Gross operating margin | 9900 | €63,167 | €73,923 | +€10,756 | +17.0% |
| Operating profit (loss) | 9901 | €61,073 | €71,808 | +€10,735 | +17.6% |
| Financial income | 75/76B | €196 | €1,298 | +€1,103 | +563% |
| Recurring financial income | 75 | €196 | €1,298 | +€1,103 | +563% |
| Financial charges | 65/66B | €5,467 | €8,944 | +€3,478 | +63.6% |
| Recurring financial charges | 65 | €5,467 | €8,944 | +€3,478 | +63.6% |
| Profit (loss) for the period before taxes | 9903 | €55,802 | €64,162 | +€8,360 | +15.0% |
| Income taxes | 67/77 | €15,964 | €16,578 | +€614 | +3.8% |
| Profit (loss) for the period | 9904 | €39,838 | €47,583 | +€7,746 | +19.4% |
| Profit (loss) for the period to be appropriated | 9905 | €39,838 | €47,583 | +€7,746 | +19.4% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.